Inhibitor Report for: 4-Oxo-beta-Lactam-LMC375General | Type | | Piperazine, beta-Lactam | | Chemical_Nomenclature | | ~{N}-[3,5-bis[[4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl]phenyl]-2-ethyl-2-methanoyl-butanamide | | Canonical SMILES | | CCC(CC)(C=O)C(=O)Nc1cc(cc(c1)CN2CCN(CC2)Cc3ccc(cc3)Br)CN4CCN(CC4)Cc5ccc(cc5)Br | | InChI | | InChI=1S/C37H47Br2N5O2/c1-3-37(4-2,28-45)36(46)40-35-22-31(26-43-17-13-41(14-18-43)24-29-5-9-33(38)10-6-29)21-32(23-35)27-44-19-15-42(16-20-44)25-30-7-11-34(39)12-8-30/h5-12,21-23,28H,3-4,13-20,24-27H2,1-2H3,(H,40,46) | | InChIKey | | FVBNIXZASNLFMF-UHFFFAOYSA-N
| | Other name(s) | | QXH |
________________________________________________________________________________________________ |
Target | Families | | | 4-Oxo-beta-Lactam-LMC375 ligand of proteins in family: DPP4N_Peptidase_S9 | | Stucture | | | 1 structure: 7A3I: Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor LMC375 | | Protein | | | human-DPP8 |
|
